PFE Pfizer Inc. Loading...

From PFE earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
14:00
Aug 04 ◎
Cécile Guégan Incoming Interim Chief Financial Officer, Pfizer, Inc. PFE Q2 FY26 call
Management raised FY2026 revenue guidance on strong non-COVID performance and maintained EPS guidance, signaling confidence in execution and offsetting COVID revenue shortfalls.
PFE
HIGH
14:00
May 05 ◎
Dave Denton CFO, Pfizer, Inc. PFE Q1 FY26 call
Pfizer raises long-term growth outlook with high single-digit CAGR post-2028, supported by legal wins and pipeline, signaling confidence in future performance.
PFE
HIGH
15:00
Feb 03 ◎
Dr. Albert Bourla Chairman & CEO, Pfizer, Inc. PFE Q4 FY25 call
Management is confident in its strategic positioning, highlighting a strong 2025 performance and a growth-oriented strategy focusing on obesity (MetCera) and oncology, despite near-term LOE headwinds.
PFE
HIGH

About PFE Analyst Coverage

Buzzberg tracks PFE (Pfizer Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 3 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: Cécile Guégan, Dave Denton, Dr. Albert Bourla.